FROM THE EDITOR IN CHIEF: Days of Future Past
Collaboration Is Key to Execute Value-Based Care for Patients With Cancer
Coverage of the Institute for Value-Based Medicine session with Zangmeister Cancer Center, Columbus, Ohio.
Novel Therapies Have Significantly Improved Melanoma Outcomes, With More Exciting Options to Come
Coverage from the Institute for Value-Based Medicine session with Minnesota Oncology.
Multiple Perspectives of Managing Cancer From the Multidisciplinary Team at Vanderbilt
Coverage from the Institute for Value-Based Medicine event with Vanderbilt University Medical Center.
Raising the Bar for Precision Oncology and Clinical Research in a Community Practice Setting
Coverage from the Institute for Value-Based Medicine session with Florida Cancer Specialists & Research Institute.
Perspectives on EOM: What Makes Sense Moving Forward
Business Highlights From Partners in Community Oncology
OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology
Coverage in Health Equity: October 2023
Health equity coverage appearing in the October 2023 issue of Evidence-Based Oncology.
Why Failing Faster Is the Key to Accelerating Drug Discovery
COVID-19 Fallout on Individuals, Economy, and Health System to Last for Years, White Paper Concludes
The Challenges of Treating Cancer When the Patient Lives Far From Care
Navigating Decision-Making When Treating Lymphoma With Bispecific Antibodies vs CAR T-Cell Therapy
COA Supports Bills to Ensure Access to Cancer Medications
The endorsements follow the group's lawsuit earlier this year to overturn CMS' interpretation of the Stark Law.
How AI and Machine Learning Can Bring Quality Improvements in Biopharma
A Mission to Cure “All the Cancers”: Crystal Denlinger, MD, FACP, Named CEO of NCCN
Denlinger, who spent most of her career at Fox Chase Cancer Center before joining the National Comprehensive Cancer Network (NCCN) as its chief scientific officer, took the helm October 9, 2023.
Unlocking the Benefits of FDA’s Orphan Drug Designation
Verily, OneOncology Create Clinical Trial Partnership to Feature Use of SignalPath Across Practices
Use of SignalPath will improve efficiency, ease compliance, boost enrollment, and ensure financial success in clinical trials, leaders said in interviews.
2 Clarke Drive Cranbury, NJ 08512